Plants as bioreactors for biopharmaceuticals: Regulatory considerations

Trends in Biotechnology

Volumn 15, Issue 2, 1997, Pages 45-50

  Miele, Lucio ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOREACTORS; DRUG PRODUCTS; ENZYMES; HORMONES; MONOCLONAL ANTIBODIES; PLANTS (BOTANY); VACCINES;

CYTOKINES;

BIOTECHNOLOGY;

CYTOKINE; ENZYME; HORMONE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; VACCINE;

BIOTECHNOLOGY; DRUG DEVELOPMENT; DRUG RESEARCH; ENVIRONMENT; PLANT; PRIORITY JOURNAL; REVIEW;

EID: 0031081649     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(97)84202-3     Document Type: Article

References (38)

1. 1 Hiatt, A. C., Cafferkey, R. and Bowdish, K. (1989) Nature 342, 76-78
2. 2 Moffat, A. S. (1995) Science 268, 658-660
3. 3 Ma, J. K-C. and Hein, M. B. (1995) Plant Physiol. 109, 341-346
4. 4 Cramer, C. L. et al. (1996) Ann. New York Acad. Sci. 792, 62-71
5. 5 Ma, J. K-C. and Hein, M. B. (1996) Ann. New York Acad. Sci. 792, 72-81
6. 6 Hein, M. B., Yeo, T-C., Wang, F. and Sturtevant, A. (1996) Ann. New York Acad. Sci. 792, 50-56
7. 7 Mason, H. S. and Arntzen, C. J. (1995) Trends Biotechnol. 13, 388-392
8. 8 Lomonossoff, G. P. (1995) Agro Food Ind. Hi Tech. 6, 7-11
9. 9 Beachy, R. N., Fitchen, J. H. and Hein, M. B. (1996) Ann. New York Acad. Sci. 792, 43-49
10. 10 Della Cioppa, G. and Grill, L. K. (1996) Ann. New York Acad. Sci. 792, 57-61
11. 11 Ma, J. K-C., Lehner, T., Stabila, P., Fux, C. I. and Hiatt, A. (1994) Eur. J. Immunol. 24, 131-138
12. 12 Saito, K., Noji, M., Ohmori, S., Imai, Y. and Murakoshi, I. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7041-7045
13. 13 Chappell, J., Proulz, J., Wolf, F., Cuellar, R. E. and Sanders, C. (1991) Plant Physiol. 96, 127
14. 14 Matsumoto, S., Ikura, K., Ueda, M. and Sasaki, R. (1995) Plant Mol. Biol. 27, 1163-1172
15. 15 Vandekerckhove, J. et al. (1989) Biotechnology 7, 929-932
16. 16 De Zoeten, G. A., Penswick, J. R., Horisberger, M. A., Ahl, P., Schultze, M. and Hohn, T. (1989) Virology 172, 213-222
17. 17 Zhu, Z. et al. (1994) Plant Cell Tissue Organ Cult. 36, 197-204
18. 18 Sijmons, P., Dekker, B. M. M., Schrammeijer, B., Versoerd, T. C., Van Den Elzen, P. J. M. and Hoekema, A. (1990) Biotechnology 8, 217-221
19. 19 Thanavala, Y., Yang, Y-F., Lyons, P., Mason, H. S. and Arntzen, C. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3358-3361
20. 20 Curtiss, R. and Cardineau, G. A. (1990) World Intellectual Property Organization, PCT/US89/03799
21. 21 Haq, T. A., Mason, H. S., Clements, J. D. and Arntzen, C. J. (1995) Science 268, 714-716
22. 22 Porta, C., Spall, V. E., Loveland, J., Johnson, J. E., Barker, P. J. and Lomonossoff, G. P. (1994) Virology 202, 949-955
23. 23 USA Food and Drug Administration (1993) Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals, FDA, Rockville, MD, USA
24. 24 USA Food and Drug Administration (1994) Points to Consider in the Manufacture and Testing of Monoclonal Anitbody Products for Human Use, an updated version will be issued in the near future, FDA, Rockville, MD, USA
25. 25 USA Food and Drug Administration (1985) Points to Consider in the Production and Testing of New Drugs and Biologicals Produced by Recombinant DNA Technology, FDA, Rockville, MD, USA
26. 26 ICH Guideline Draft Q5D Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products derived from Cell lines of Human or Animal origin, US Federal Register 61, May 1996
27. 27 Nose, M. and Wigzell, H. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 6632-6636
28. 28 Rademacher, T. W. and Dwek, R. A. (1983) in Progress in Immunology V (Yamamura, Y. and Tada, T., eds), pp. 95-112, Academic Press
29. 29 Tachibana, H. et al. (1994) Cytotechnology 16, 151-157
30. 30 Leung, S. O. et al. (1995) Int. J. Cancer 60, 534-538
31. 31 Kim, H. et al. (1994) J. Biol. Chem. 269, 12345-12350
32. 32 Thotakura, N. R. and Blithe, D. L. (1995) Glycobiology 5, 3-10
33. 33 Flack, M. R., Bennet, A. P., Froehlich, J., Anasti, J. N. and Nisula, B. C. (1994) J. Clin. Endocrinol. Metab. 79, 756-760
34. 34 Takeuchi, M. et al. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7819-7822
35. 35 Misaizu, T. et al. (1995) Blood 86, 4097-4104
36. 36 Von Scaeven, A., Sturm, A., O'Neill, J. and Chrispeels, M. J. (1993) Plant Physiol. 102, 1109-1118
37. 37 FDA (1996) FDA Guidance Concerning Demonstration of Comparability of Human Biological Products, Including Therapeutic Biotechnology-derived Products, FDA, Rockville, MD, USA
38. 38 Bright, S. W., Greenland, A. J., Halpin, C. M., Schuch, W. W. and Dunwell, J. (1996) Ann. New York Acad. Sci. 792, 99-105